For Life Sciences companies, Real World Evidence (RWE) initiatives present a golden opportunity to demonstrate the clinical and economic value of their drugs and medical devices and to get those products to market faster. However, the success of RWE development efforts depends heavily upon your organization’s capacity to generate results in a comprehensive and cost-efficient manner.
MarkLogic’s database is the ideal technology platform for the development of RWE because it provides key enterprise capabilities that enable rapid data integration and harmonization; data governance, privacy, and quality assurance; semantic search for faster time to insight.
Your Real World Data assets are growing, but your solution can’t keep up with your need for critical answers and faster insights. Is your technology holding you back? Learn what you can do to extract more value from your data.
Tasked with the unprecedented undertaking of providing health insurance to millions of uninsured Americans, the Centers for Medicare & Medicaid Services (CMS) concluded that MarkLogic’s database platform provided the scalability and agility required to meet an 18-month timeframe from software procurement to launch.
Disparate Real World data sets must be fully integrated to generate effective Real World Evidence.
Extracting more value from healthcare data is key to leveraging Real World Evidence. This leads to faster time to insight. Is your organization equipped for success?
MarkLogic built a metadata catalog for a global leader in biotech–enabling researchers to efficiently filter through metadata to zero-in on data sets with patient candidates and studies most relevant to their areas of research, gaining faster insights and competitive advantage.
You can expand beyond inefficient point-to-point SOA data integration to unify your enterprise with a data-centric, Operational Data Hub architecture.
